{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:23:08Z","timestamp":1784751788029,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T00:00:00Z","timestamp":1072828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1038\/sj.npp.1300392","type":"journal-article","created":{"date-parts":[[2004,3,24]],"date-time":"2004-03-24T10:27:14Z","timestamp":1080124034000},"page":"969-981","source":"Crossref","is-referenced-by-count":163,"title":["Agonist-Like or Antagonist-Like Treatment for Cocaine Dependence with Methadone for Heroin Dependence: Two Double-Blind Randomized Clinical Trials"],"prefix":"10.1038","volume":"29","author":[{"given":"John","family":"Grabowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Rhoades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Stotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kopecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Gerard","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohela","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,12,31]]},"reference":[{"key":"BF1300392_CR1","first-page":"178","volume":"86","author":"JC Ball","year":"1988","unstructured":"Ball JC, Corty E (1988). Basic issues pertaining to the effectiveness of methadone maintenance treatment. NIDA Res Monogr 86: 178\u2013191.","journal-title":"NIDA Res Monogr"},{"key":"BF1300392_CR2","first-page":"215","volume":"29","author":"MD Bano","year":"2001","unstructured":"Bano MD, Mico JA, Aguietas M, Lopez ML, Guillen JL (2001). Olanzapine efficacy in the treatment of cocaine abuse in methadone maintenance patients. Interactions and plasma levels (abstract English). Actas Esp Psiquiatria 29: 215\u2013220.","journal-title":"Actas Esp Psiquiatria"},{"key":"BF1300392_CR3","volume-title":"Beck Depression Inventory","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK (1996). Beck Depression Inventory, 2nd edn. The Psychological Corporation: San Antonio, TX."},{"key":"BF1300392_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/j.1552-4604.1983.tb02706.x","volume":"23","author":"DL Bourke","year":"1983","unstructured":"Bourke DL, Allen PD, Rosenberg M, Mendes RW, Karabelas AN (1983). Dextroamphetamine with morphine: respiratory effects. J Clin Pharmacol 23: 65\u201370.","journal-title":"J Clin Pharmacol"},{"key":"BF1300392_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0376-8716(98)00052-0","volume":"52","author":"B Charnaud","year":"1998","unstructured":"Charnaud B, Griffiths V (1998). Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison. Drug Alcohol Depend 52: 79\u201384.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300392_CR6","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd edn Lawrence Erlbaum Associates: Hillsdale, NJ."},{"key":"BF1300392_CR7","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders\u2013Patient Edition","author":"M First","year":"1995","unstructured":"First M, Spitzer R, Gibbon M, Williams J (1995). Structured Clinical Interview for DSM-IV Axis I Disorders\u2013Patient Edition. New York State Psychiatric Institute: New York."},{"key":"BF1300392_CR8","first-page":"623","volume":"261","author":"RW Foltin","year":"1992","unstructured":"Foltin RW, Fischman MW (1992). The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Therapeut 261: 623\u2013632.","journal-title":"J Pharmacol Exp Therapeut"},{"key":"BF1300392_CR9","first-page":"1153","volume":"278","author":"RW Foltin","year":"1996","unstructured":"Foltin RW, Fischman MW (1996). Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Therapeut 278: 1153\u20131164.","journal-title":"J Pharmacol Exp Therapeut"},{"key":"BF1300392_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1046\/j.1360-0443.1998.9368254.x","volume":"93","author":"RW Foltin","year":"1998","unstructured":"Foltin RW, Fischman MW (1998). Effects of \u2018binge\u2019 use of intravenous cocaine in methadone-maintained individuals. Addiction 93: 825\u2013836.","journal-title":"Addiction"},{"key":"BF1300392_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJM197703312961303","volume":"296","author":"WH Forrest Jr","year":"1977","unstructured":"Forrest Jr WH, Brown Jr BW, Brown CR, Defalque R, Gold M, Gordon HE et al (1977). Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 296: 712\u2013715.","journal-title":"N Engl J Med"},{"key":"BF1300392_CR12","volume-title":"The Pharmacological Basis of Therapeutics","author":"L Goodman","year":"1941","unstructured":"Goodman L, Gilman A (1941). The Pharmacological Basis of Therapeutics. The Macmillan Co.: NY."},{"key":"BF1300392_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/00952997909001724","volume":"6","author":"J Grabowski","year":"1979","unstructured":"Grabowski J, O\u2019Brien CP, Greenstein R, Ternes J, Long M, Steinberg-Donato S (1979). Effects of contingent payment on compliance with a naltrexone regimen. Am J Drug Alcohol Abuse 6: 355\u2013365.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BF1300392_CR14","first-page":"675","volume":"150","author":"J Grabowski","year":"1993","unstructured":"Grabowski J, Rhoades H, Elk R, Schmitz J, Creson D (1993). Methadone dosage, cocaine and opiate abuse [letter]. Am J Psychiatry 150: 675.","journal-title":"Am J Psychiatry"},{"key":"BF1300392_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00004714-199506000-00004","volume":"15","author":"J Grabowski","year":"1995","unstructured":"Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D et al (1995). Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharmacol 15: 163\u2013174.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300392_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","volume":"21","author":"J Grabowski","year":"2001","unstructured":"Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D et al (2001). Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21: 522\u2013526; (Also summarized and reviewed in Evidence Based Medicine: Mental Health, 2002).","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300392_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00004714-200006000-00003","volume":"20","author":"J Grabowski","year":"2000","unstructured":"Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D et al (2000a). Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmacol 20: 305\u2013310.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300392_CR18","first-page":"216","volume":"60","author":"J Grabowski","year":"2000","unstructured":"Grabowski J, Rhoades H, Stotts A, Schmitz J, Creson D, Moeller G et al (2000b). D-amphetamine for treatment of cocaine dependence: randomized double blind placebo controlled trials. Drug Alcohol Depend (Abstracts CPDD) 60: 216.","journal-title":"Drug Alcohol Depend (Abstracts CPDD)"},{"key":"BF1300392_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/00952998109009554","volume":"8","author":"RA Greenstein","year":"1981","unstructured":"Greenstein RA, O\u2019Brien CP, McLellan AT, Woody GE, Grabowski J, Long M et al (1981). Naltrexone: a short-term treatment for opiate dependence. Am J Drug Alcohol Abuse 8: 291\u2013300.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BF1300392_CR20","first-page":"182","volume":"37","author":"RR Griffiths","year":"1981","unstructured":"Griffiths RR, Brady JV, Bigelow GE (1981). Predicting the dependence liability of stimulant drugs. NIDA Res Monog 37: 182\u2013196; (Washington DC. DHHS (ADM) 81-1137).","journal-title":"NIDA Res Monog"},{"issue":"Suppl 4","key":"BF1300392_CR21","doi-asserted-by":"publisher","first-page":"s3","DOI":"10.1097\/00004850-199709004-00002","volume":"12","author":"R Gutierrez-Esteinou","year":"1997","unstructured":"Gutierrez-Esteinou R, Grebb JA (1997). Risperidone: an analysis of the first three years in general use. Int Clin Psychopharmacol 12 (Suppl 4): s3\u2013s10.","journal-title":"Int Clin Psychopharmacol"},{"key":"BF1300392_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0376-8716(86)90031-1","volume":"17","author":"DR Jasinski","year":"1986","unstructured":"Jasinski DR, Preston KL (1986). Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects. Drug Alcohol Depend 17: 1\u201313.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300392_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00213-002-1207-y","volume":"163","author":"LL Howell","year":"2002","unstructured":"Howell LL, Wilcox KM (2002). Functional imaging and neurochemical correlates of stimulant self-administration in primates. Psychopharmacology 163: 352\u2013361.","journal-title":"Psychopharmacology"},{"key":"BF1300392_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1037\/1064-1297.10.2.136","volume":"10","author":"EC Katz","year":"2002","unstructured":"Katz EC, Chutuape MA, Jones HE, Stitzer ML (2002). Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program. Exp Clin Psychopharmacol 10: 136\u2013143.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1300392_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/09595230120092715","volume":"20","author":"H Klee","year":"2001","unstructured":"Klee H, Wright S, Carnwath T, Merrill J (2001). The role of substitute therapy in the treatment of problem amphetamine use. Drug Alcohol Rev 20: 417\u2013429.","journal-title":"Drug Alcohol Rev"},{"key":"BF1300392_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0091-3057(98)00021-5","volume":"60","author":"X Lamas","year":"1998","unstructured":"Lamas X, Negus SS, Gatch MB, Mello NK (1998). Effects of heroin\/cocaine combinations in rats trained to discriminate heroin or cocaine from saline. Pharmacol Biochem Behav 60: 357\u2013364.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300392_CR27","first-page":"800","volume-title":"Neuro-Psycho-Pharmacology","author":"VG Laties","year":"1967","unstructured":"Laties VG, Weiss B (1967). Performance enhancement by the amphetamines: a new appraisal. In: Brill H et al (eds) Neuro-Psycho-Pharmacology. Excerpta Medica Foundation: Amsterdam. pp 800\u2013808."},{"key":"BF1300392_CR28","first-page":"2689","volume":"40","author":"VG Laties","year":"1981","unstructured":"Laties VG, Weiss B (1981). The amphetamine margin in sports. Fed Proc 40: 2689\u20132692.","journal-title":"Fed Proc"},{"key":"BF1300392_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","volume":"98","author":"F Leri","year":"2003","unstructured":"Leri F, Bruneau J, Stewart J (2003). Understanding polydrug use: review of heroin and cocaine co-use. Addiction 98: 7\u201322.","journal-title":"Addiction"},{"key":"BF1300392_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/105504999305929","volume":"8","author":"FR Levin","year":"1999","unstructured":"Levin FR, McDowell D, Evans SM, Brooks D, Spano C, Nunes EV (1999). Pergolide mesylate for cocaine abuse: a controlled preliminary trial. Am J Addict 8: 120\u2013127.","journal-title":"Am J Addict"},{"key":"BF1300392_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0166-4328(01)00164-4","volume":"121","author":"C Manzanedo","year":"2001","unstructured":"Manzanedo C, Aguilar MA, Rodriguez-Arias M, Minarro J (2001). Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res 121: 189\u2013197.","journal-title":"Behav Brain Res"},{"key":"BF1300392_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1300\/J069v21n03_01","volume":"21","author":"S Maxwell","year":"2002","unstructured":"Maxwell S, Shinderman MS (2002). Optimizing long term response to methadone maintenance treatment: a 152-week Follow-up using higher dose methadone. J Addict Dis 21: 1\u201312.","journal-title":"J Addict Dis"},{"key":"BF1300392_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","volume":"8","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, Kusher H, Metzger D, Peters R, Smith I, Grisson G et al (1992). The fifth edition of the Addiction Severity Index. J Substance Abuse Treat 8: 199\u2013213.","journal-title":"J Substance Abuse Treat"},{"key":"BF1300392_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/104345428600300109","volume":"3","author":"MJ McManus","year":"1986","unstructured":"McManus MJ, Panzarella C (1986). The use of dextroamphetamine to counteract sedation for patients on a morphine drip. J Assoc Pediatr Oncol Nurses 3: 28\u201329.","journal-title":"J Assoc Pediatr Oncol Nurses"},{"key":"BF1300392_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0014-2999(97)01351-4","volume":"340","author":"WM Meil","year":"1997","unstructured":"Meil WM, Schecter MD (1997). Olanzapine attenuates the reinforcing effects of cocaine. Eur J Pharmacol 340: 17\u201326.","journal-title":"Eur J Pharmacol"},{"key":"BF1300392_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","volume":"14","author":"NK Mello","year":"1996","unstructured":"Mello NK, Negus SS (1996). Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14: 375\u2013424.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300392_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0893-133X(00)00247-5","volume":"25","author":"NK Mello","year":"2001","unstructured":"Mello NK, Negus SS (2001). Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys. Neuropsychopharmacology 25: 104\u2013117.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300392_CR38","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/sj.npp.1300096","volume":"28","author":"SS Negus","year":"2003","unstructured":"Negus SS (2003). Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 28: 919\u2013931.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300392_CR39","first-page":"1123","volume":"285","author":"SS Negus","year":"1998","unstructured":"Negus SS, Gatch MB, Mello NK (1998). Discriminative stimulus effects of a cocaine\/heroin \u2018speedball\u2019 combination in Rhesus monkeys. J Pharmacol Exp Therapeut 285: 1123\u20131136.","journal-title":"J Pharmacol Exp Therapeut"},{"key":"BF1300392_CR40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00213-003-1409-y","volume":"167","author":"SS Negus","year":"2003","unstructured":"Negus SS, Mello NK (2003a). Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology 167: 324\u2013332.","journal-title":"Psychopharmacology"},{"key":"BF1300392_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0376-8716(02)00339-3","volume":"70","author":"SS Negus","year":"2003","unstructured":"Negus SS, Mello NK (2003b). Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70: 39\u201352.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300392_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0165-1781(01)00255-4","volume":"102","author":"TF Newton","year":"2001","unstructured":"Newton TF, Ling W, Kalechstein AD, Uslaner J, Tervo K (2001). Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Res 102: 227\u2013233.","journal-title":"Psychiatry Res"},{"key":"BF1300392_CR43","first-page":"1755","volume":"150","author":"A Oliveto","year":"1993","unstructured":"Oliveto A, Kosten T, Schottenfeld R, Ziedonis D (1993). Cocaine abuse among methadone-maintained patients. Am J Psychiatry 150: 1755.","journal-title":"Am J Psychiatry"},{"key":"BF1300392_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00213-002-1137-8","volume":"163","author":"DM Platt","year":"2002","unstructured":"Platt DM, Rowlett JK, Spealman RD (2002). Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 163: 265\u2013282.","journal-title":"Psychopharmacology"},{"key":"BF1300392_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0376-8716(98)00152-5","volume":"54","author":"KL Preston","year":"1999","unstructured":"Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR (1999). Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend 54: 127\u2013135.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300392_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0014-2999(00)00442-8","volume":"402","author":"T Rasmussen","year":"2000","unstructured":"Rasmussen T, Sauerberg P, Nielsen EB, Swedberg MDB, Thomsen C, Sheardown MJ et al (2000). Muscarinic receptor agonists decrease cocaine self-administration rates in drug na\u00efve mice. Eur J Pharmacol 402: 241\u2013246.","journal-title":"Eur J Pharmacol"},{"key":"BF1300392_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2105\/AJPH.88.1.34","volume":"88","author":"HM Rhoades","year":"1998","unstructured":"Rhoades HM, Creson D, Elk R, Schmitz JM, Grabowski J (1998). Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 88: 34\u201339.","journal-title":"Am J Public Health"},{"key":"BF1300392_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1749-6632.2002.tb04155.x","volume":"965","author":"RB Rothman","year":"2002","unstructured":"Rothman RB, Blough BE, Baumann MH (2002). Appetite suppressants as agonist substitution therapies for stimulant dependence. Ann NY Acad Sci 965: 109\u2013126.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300392_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1521-0391.1998.tb00473.x","volume":"7","author":"A Roy","year":"1998","unstructured":"Roy A, Roy M, Smelson DA (1998). Risperidone, ERG and cocaine craving [letter]. Am J Addict 7: 90.","journal-title":"Am J Addict"},{"key":"BF1300392_CR50","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/09595230220139082","volume":"21","author":"J Shearer","year":"2002","unstructured":"Shearer J, Sherman J, Wodak A, Van Beek I (2002). Substitution therapy for amphetamine users. Drug Alcohol Rev 21: 179\u2013185.","journal-title":"Drug Alcohol Rev"},{"key":"BF1300392_CR51","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","volume":"98","author":"J Shearer","year":"2003","unstructured":"Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J (2003). Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98: 1137\u20131141.","journal-title":"Addiction"},{"key":"BF1300392_CR52","unstructured":"Shearer J, Wodak A, Mattick RP, van Beek I, Lewis J, Hall W et al (1999). A randomised controlled trial of feasibility of monitoring controlled prescribing of dexamphetamine. NDARC Technical Report, National Drug and Alcohol Research Centre, University of New South Wales, pp 1\u201343."},{"key":"BF1300392_CR53","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1046\/j.1360-0443.2001.96912898.x","volume":"96","author":"J Shearer","year":"2001","unstructured":"Shearer J, Wodak A, Mattick RP, Van Beek I, Lewis J, Hall W et al (2001). Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction 96: 1289\u20131296.","journal-title":"Addiction"},{"key":"BF1300392_CR54","first-page":"1268","volume":"148","author":"SM Stine","year":"1991","unstructured":"Stine SM, Burns B, Kosten T (1991). Methadone dose for cocaine abuse. Am J Psychiatry 148: 1268.","journal-title":"Am J Psychiatry"},{"key":"BF1300392_CR55","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","volume":"281","author":"EC Strain","year":"1999","unstructured":"Strain EC, Bigelow GE, Liebson IA, Stitzer ML (1999). Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial [see comments]. J Am Med Assoc 281: 1000\u20131005.","journal-title":"J Am Med Assoc"},{"key":"BF1300392_CR56","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0091-3057(99)00146-X","volume":"64","author":"N Van Campenhout","year":"1999","unstructured":"Van Campenhout N, De Haes P, Meert TF (1999). Inability of antipsychotics to antagonize the cueing properties of cocaine in rats. Pharmacol Biochem Behav 64: 435\u2013438.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300392_CR57","volume-title":"Twenty Common Problems in Cardiology","author":"MM Velasquez","year":"2003","unstructured":"Velasquez MM, Wright K, Ingersoll KS (2003). Treatment adherence and cardiovascular disease. In: Fowler G (ed). Twenty Common Problems in Cardiology. McGraw-Hill: New York."},{"key":"BF1300392_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1081\/ADA-120002971","volume":"28","author":"CL Villano","year":"2002","unstructured":"Villano CL, Rosenblum A, Magura S, Fong C (2002). Improving treatment engagement and outcomes for cocaine-using methadone patients. Am J Drug Alcohol Abuse 28: 213\u2013230.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BF1300392_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0376-8716(02)00104-7","volume":"68","author":"SR Wachtel","year":"2002","unstructured":"Wachtel SR, Ortengren A, de Wit H (2002). The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend 68: 23\u201333.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300392_CR60","first-page":"1","volume":"14","author":"B Weiss","year":"1962","unstructured":"Weiss B, Laties VG (1962). Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev 14: 1\u201336.","journal-title":"Pharmacol Rev"},{"key":"BF1300392_CR61","first-page":"32","volume-title":"The Correlation of Adverse Effects in Man with Observations in Animals","author":"B Weiss","year":"1970","unstructured":"Weiss B, Laties VG (1970). Reconciling the effects of amphetamine on human and animal behavior. In: de C Baker SB (ed). The Correlation of Adverse Effects in Man with Observations in Animals. Excerpta Medica Foundation: Amsterdam. pp 32\u201336."},{"key":"BF1300392_CR62","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00004714-199906000-00010","volume":"19","author":"JD Wines","year":"1999","unstructured":"Wines JD, Weiss RD (1999). Opioid withdrawal during risperidone treatment. J Clin Psychopharmacol 19: 265\u2013266.","journal-title":"J Clin Psychopharmacol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300392","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:45:50Z","timestamp":1684219550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,31]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["BF1300392"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300392","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,31]]}}}